Medical Doctor Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

Pier Pasquale Leone

Interventional Cardiology New York, NY Medical Doctor

NPI 1609576735 CMS profile 11444572

Mount Sinai Hospital-One Gustabe L. Levy Place, Bldg 2, New York, NY 10029

Open in the dashboard

General payments

$43,293

256 records reported · program years 2023–2025

Research payments

$0

Paid to them · None reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Pier Pasquale Leone of New York, NY is reported in the CMS Open Payments database as having received $43,293 across 256 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 85th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,232 84
2024 General $35,008 113
2023 General $2,053 59

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Pier Pasquale Leone
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Pier Pasquale Leone were reported at $6,232. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Pier Pasquale Leone Interventional Cardiology median Middle half National median
2019 $0 $1,097 $329–$3,048 $163
2020 $0 $473 $161–$1,480 $114
2021 $0 $677 $233–$1,827 $132
2022 $0 $978 $333–$2,724 $149
2023 $2,053 $1,136 $382–$2,986 $160
2024 $35,008 $1,181 $395–$3,326 $164
2025 $6,232 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. Medtronic, Inc. $32,901 50 payments
  2. Edwards Lifesciences Corporation $3,715 45 payments
  3. W. L. Gore & Associates, Inc. $2,296 32 payments
  4. Shockwave Medical, Inc $1,098 25 payments
  5. Abiomed $1,072 26 payments
  6. Terumo Medical Corporation $726 22 payments
  7. Boston Scientific Corporation $416 12 payments
  8. Chiesi USA, Inc. $245 11 payments
  9. Cardiva Medical, Inc. $187 7 payments
  10. Bard Peripheral Vascular, Inc. $178 8 payments
  11. Other $458 18 payments

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Grant $30,000 1 payment
  2. Food and Beverage $11,030 241 payments
  3. Travel and Lodging $2,078 12 payments
  4. Education $184 2 payments
Products named General payments · program years 2023–2025
  1. COREVALVE EVOLUT R $32,322 41 payments
  2. GORE CARDIOFORM Septal Occluder $1,359 18 payments
  3. PASCAL $1,236 15 payments
  4. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $1,202 12 payments
  5. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $954 23 payments
  6. GORE CARDIOFORM ASD Occluder $786 10 payments
  7. Impella $651 23 payments
  8. EVOQUE $498 2 payments
  9. SAPIEN 3 Ultra RESILIA $447 9 payments
  10. SYMPLICITY G3 $307 6 payments
  11. Other $2,757 87 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

256 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record